Terms: = Prostate cancer AND PDGFRB, JTK12, 5159, P09619, ENSG00000113721, PDGF-R-beta, PDGFR1, CD140B, PDGFR, CD140b
78 results:
1. From nature to cancer therapy: Evaluating the Streptomyces clavuligerus secondary metabolites for potential protein kinase inhibitors.
Saini R; Kumari S; Singh A; Mishra A
J Cell Biochem; 2024 Jan; 125(1):59-78. PubMed ID: 38047468
[TBL] [Abstract] [Full Text] [Related]
2. Association of True Positivity with Serum prostate-Specific Antigen Levels and Other Clinical Factors in Indeterminate PSMA-RADS-3A Lesions Identified on
Garg T; Werner RA; Chung HW; Khatri W; Pienta KJ; Pomper MG; Gorin MA; Saad E; Rowe SP
Tomography; 2022 Oct; 8(6):2639-2647. PubMed ID: 36412679
[TBL] [Abstract] [Full Text] [Related]
3. Proteomic characterisation of prostate cancer intercellular communication reveals cell type-selective signalling and TMSB4X-dependent fibroblast reprogramming.
Wu Y; Clark KC; Nguyen EV; Niranjan B; Horvath LG; Taylor RA; Daly RJ
Cell Oncol (Dordr); 2022 Dec; 45(6):1311-1328. PubMed ID: 36169805
[TBL] [Abstract] [Full Text] [Related]
4. Spindle pole body component 25 and platelet-derived growth factor mediate crosstalk between tumor-associated macrophages and prostate cancer cells.
Cui F; Xu Z; Hu J; Lv Y
Front Immunol; 2022; 13():907636. PubMed ID: 35967419
[TBL] [Abstract] [Full Text] [Related]
5. Neuropilin-1 is over-expressed in claudin-low breast cancer and promotes tumor progression through acquisition of stem cell characteristics and RAS/MAPK pathway activation.
Tang YH; Rockstroh A; Sokolowski KA; Lynam LR; Lehman M; Thompson EW; Gregory PA; Nelson CC; Volpert M; Hollier BG
Breast Cancer Res; 2022 Jan; 24(1):8. PubMed ID: 35078508
[TBL] [Abstract] [Full Text] [Related]
6. Imatinib mesylate inhibits androgen-independent PC-3 cell viability, proliferation, migration, and tumor growth by targeting platelet-derived growth factor receptor-α.
Nayeem MJ; Yamamura A; Hayashi H; Muramatsu H; Nakamura K; Sassa N; Sato M
Life Sci; 2022 Jan; 288():120171. PubMed ID: 34822800
[TBL] [Abstract] [Full Text] [Related]
7. Clinically Significant prostate cancer Detection After a Negative Prebiopsy MRI Examination: Comparison of Biparametric Versus Multiparametric MRI.
Gan JM; Kikano EG; Smith DA; Rao S; Podury R; Wang M; Durieux JC; Paspulati RM; Ponsky L; Ramaiya NH; Tirumani SH
AJR Am J Roentgenol; 2022 May; 218(5):859-866. PubMed ID: 34817189
[No Abstract] [Full Text] [Related]
8. Erectile Function Following Surgery for Benign Prostatic Obstruction: A Systematic Review and Network Meta-analysis of Randomised Controlled Trials.
Light A; Jabarkhyl D; Gilling P; George G; Van Hemelrijck M; Challacombe B; Malde S; Popert R; Dasgupta P; Elhage O
Eur Urol; 2021 Aug; 80(2):174-187. PubMed ID: 34127315
[TBL] [Abstract] [Full Text] [Related]
9. prostate cancer follow-up costs in Germany from 2000 to 2015.
Michaeli T; Michaeli D
J Cancer Surviv; 2022 Feb; 16(1):86-94. PubMed ID: 33646503
[TBL] [Abstract] [Full Text] [Related]
10. Anticancer evaluation and molecular modeling of multi-targeted kinase inhibitors based pyrido[2,3-d]pyrimidine scaffold.
Elzahabi HSA; Nossier ES; Khalifa NM; Alasfoury RA; El-Manawaty MA
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):546-557. PubMed ID: 29482389
[TBL] [Abstract] [Full Text] [Related]
11. GANT-61 and GDC-0449 induce apoptosis of prostate cancer stem cells through a GLI-dependent mechanism.
Tong W; Qiu L; Qi M; Liu J; Hu K; Lin W; Huang Y; Fu J
J Cell Biochem; 2018 Apr; 119(4):3641-3652. PubMed ID: 29231999
[TBL] [Abstract] [Full Text] [Related]
12. High expression of pdgfr-β in prostate cancer stroma is independently associated with clinical and biochemical prostate cancer recurrence.
Nordby Y; Richardsen E; Rakaee M; Ness N; Donnem T; Patel HR; Busund LT; Bremnes RM; Andersen S
Sci Rep; 2017 Feb; 7():43378. PubMed ID: 28233816
[TBL] [Abstract] [Full Text] [Related]
13. Imatinib Spares cKit-Expressing prostate Neuroendocrine Tumors, whereas Kills Seminal Vesicle Epithelial-Stromal Tumors by Targeting pdgfr-β.
Jachetti E; Rigoni A; Bongiovanni L; Arioli I; Botti L; Parenza M; Cancila V; Chiodoni C; Festinese F; Bellone M; Tardanico R; Tripodo C; Colombo MP
Mol Cancer Ther; 2017 Feb; 16(2):365-375. PubMed ID: 27980106
[TBL] [Abstract] [Full Text] [Related]
14. PDGF-AA mediates mesenchymal stromal cell chemotaxis to the head and neck squamous cell carcinoma tumor microenvironment.
Watts TL; Cui R; Szaniszlo P; Resto VA; Powell DW; Pinchuk IV
J Transl Med; 2016 Dec; 14(1):337. PubMed ID: 27931212
[TBL] [Abstract] [Full Text] [Related]
15. Matriptase activation and shedding through PDGF-D-mediated extracellular acidosis.
Najy AJ; Dyson G; Jena BP; Lin CY; Kim HR
Am J Physiol Cell Physiol; 2016 Feb; 310(4):C293-304. PubMed ID: 26157007
[TBL] [Abstract] [Full Text] [Related]
16. Regulation of prostate stromal fibroblasts by the PIM1 protein kinase.
Zemskova MY; Song JH; Cen B; Cerda-Infante J; Montecinos VP; Kraft AS
Cell Signal; 2015 Jan; 27(1):135-46. PubMed ID: 25451079
[TBL] [Abstract] [Full Text] [Related]
17. Proteinase-activated receptor 1- and 4-promoted migration of Hep3B hepatocellular carcinoma cells depends on ROS formation and RTK transactivation.
Mußbach F; Henklein P; Westermann M; Settmacher U; Böhmer FD; Kaufmann R
J Cancer Res Clin Oncol; 2015 May; 141(5):813-25. PubMed ID: 25373316
[TBL] [Abstract] [Full Text] [Related]
18. PDGF receptors in tumor biology: prognostic and predictive potential.
Paulsson J; Ehnman M; Östman A
Future Oncol; 2014; 10(9):1695-708. PubMed ID: 25145436
[TBL] [Abstract] [Full Text] [Related]
19. High density of S100A9 positive inflammatory cells in prostate cancer stroma is associated with poor outcome.
Tidehag V; Hammarsten P; Egevad L; Granfors T; Stattin P; Leanderson T; Wikström P; Josefsson A; Hägglöf C; Bergh A
Eur J Cancer; 2014 Jul; 50(10):1829-1835. PubMed ID: 24726733
[TBL] [Abstract] [Full Text] [Related]
20. Immunohistochemical expression of pdgfr, VEGF-C, and proteins of the mToR pathway before and after androgen deprivation therapy in prostate carcinoma: significant decrease after treatment.
Kozakowski N; Hartmann C; Klingler HC; Susani M; Mazal PR; Scharrer A; Haitel A
Target Oncol; 2014 Dec; 9(4):359-66. PubMed ID: 24243494
[TBL] [Abstract] [Full Text] [Related]
[Next]
